Allergan, Richter's bipolar depression drug succeeds in key trial

(Reuters) - Allergan Plc and Hungary's Gedeon Richter Plc said on Monday their drug to treat severe bipolar depression in adults met the main goal of a late-stage study, bringing the them closer to getting another approval for the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news